S.PattanashettarR.YernaleN
A 2026 meta-analysis published in eClinicalMedicine found that weight regain plateaus at 75.3% of weight lost after GLP-1 medication cessation , and discontinuation rates are high
Novo Nordisk and Eli Lilly turn their attention to GLP-1 effects on alcohol As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two pharma giants that are responsible for the development of the current crop of blockbuster GLP-1 drugs: Novo Nordisk and Eli Lilly
If youve experienced health issues after taking Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, or Victoza, you might have a case
Research has examined how NNMT may participate in such changes within adipose tissue
Autism spectrum disorder Numerous studies have shown that children with autism spectrum disorder (ASD) exhibit abnormalities in oxidative stress markers